Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?

被引:27
|
作者
Peck, Larissa [1 ,2 ]
Borle, Kennedy [3 ]
Folkersen, Lasse [4 ]
Austin, Jehannine [1 ,5 ]
机构
[1] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[4] Mental Hlth Ctr Sankt Hans, Inst Biol Psychiat, Copenhagen, Denmark
[5] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
关键词
EXPERIENCES; CANCER; IMPACT;
D O I
10.1038/s41431-021-00929-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We sought to explore individuals' motivations for using their direct-to-consumer genetic testing data to generate polygenic risk scores (PRSs) using a not-for-profit third-party tool, and to assess understanding of, and reaction to their results. Using a cross-sectional design, users of Impute.me who had already accessed PRS results were invited to complete an online questionnaire asking about demographics, motivations for seeking PRSs, understanding and interpretation of PRSs, and two validated scales regarding reactions to results-the Impact of Event Scale Revised (IES-R) and the Feelings About genomiC Testing Results (FACToR). Independent samples T-tests and ANOVA were used to explore associations between the variables. 227 individuals participated in the study. The most frequently reported motivation was general curiosity (98.2%). Only 25.6% of participants correctly answered all questions assessing understanding/interpretation of PRSs. Over half of participants (60.8%) experienced a negative reaction (upset, anxious, and/or sad on FACToR scale) after receiving their PRSs and 5.3% scored over the threshold for potential post-traumatic stress disorder on the IES-R. Lower understanding about PRS was associated with experiencing a negative psychological reaction (P values <0.001). Higher quality pre-test information, particularly to improve understanding, and manage expectations for PRS may be useful in limiting negative psychological reactions.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 19 条
  • [1] Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?
    Larissa Peck
    Kennedy Borle
    Lasse Folkersen
    Jehannine Austin
    [J]. European Journal of Human Genetics, 2022, 30 : 81 - 87
  • [2] Polygenic risk scores: how much do they add?
    Christoffersen, Mette
    Tybjaerg-Hansen, Anne
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 157 - 162
  • [3] Do we measure or compute polygenic risk scores? Why language matters
    Penders, Bart
    Janssens, A. Cecile J. W.
    [J]. HUMAN GENETICS, 2022, 141 (05) : 1093 - 1097
  • [4] Do we measure or compute polygenic risk scores? Why language matters
    Bart Penders
    A. Cecile J. W. Janssens
    [J]. Human Genetics, 2022, 141 : 1093 - 1097
  • [5] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Hadley, Trevor D.
    Agha, Ali M.
    Ballantyne, Christie M.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (06)
  • [6] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Trevor D. Hadley
    Ali M. Agha
    Christie M. Ballantyne
    [J]. Current Atherosclerosis Reports, 2021, 23
  • [7] THE GENETIC ARCHITECTURE OF SCHIZOPHRENIA: HOW DO CNVS AND POLYGENIC SCORES CONTRIBUTE TO DISEASE RISK?
    Bergen, Sarah E.
    Smoller, Jordan
    Sebat, Jonathan
    Purcell, Shaun
    Neale, Benjamin
    Kendler, Kenneth
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S62 - S62
  • [8] How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?
    Moorthy, Tiahna
    Nguyen, Huyan
    Chen, Ying
    Austin, Jehannine
    Smoller, Jordan W.
    Hercher, Laura
    Sabatello, Maya
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2023, 192 (7-8) : 161 - 170
  • [9] How (or Do) People "Think" About Cancer Risk, and Why That Matters
    Klein, William M. P.
    Ferrer, Rebecca A.
    Kaufman, Annette R.
    [J]. JAMA ONCOLOGY, 2020, 6 (07) : 983 - 984
  • [10] Genetic testing and risk interpretation: How do women understand lifetime risk results?
    Hanoch, Yaniv
    Miron-Shatz, Talya
    Himmelstein, Mary
    [J]. JUDGMENT AND DECISION MAKING, 2010, 5 (02): : 116 - 123